Cover Image
市場調查報告書

細胞化驗 (細胞化驗分析):全球產業及市場展望 (2016-2026年)

Cell-Based Assays - World Industry and Market Prospects 2016-2026: Products, Services, Drug Discovery, ADME and Basic Research

出版商 Visiongain Ltd 商品編碼 233145
出版日期 內容資訊 英文 185 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
細胞化驗 (細胞化驗分析):全球產業及市場展望 (2016-2026年) Cell-Based Assays - World Industry and Market Prospects 2016-2026: Products, Services, Drug Discovery, ADME and Basic Research
出版日期: 2016年05月26日 內容資訊: 英文 185 Pages
簡介

本報告提供全球細胞化驗 (細胞化驗分析)的市場調查,彙整細胞化驗概要,用途,優點,全球及主要國家的市場規模變化與預測,產品/服務各種類及各用途分析,主要的產品供應商及CRO/服務供應商簡介,細胞化驗技術趨勢與未來展望等相關資訊。

第1章 報告概要

第2章 簡介:細胞化驗及其用途

  • 探索新藥的發現·開發成本和企業的高效率化
  • 藥物發現方法:標靶型與表現型
  • 藥物篩檢化驗
  • 動物模式:In Vivo可否適用人類?
  • 生物化學化驗和動物模式具有的優點
  • 細胞化驗及其優點
  • 2D細胞化驗 vs 3D細胞化驗
  • 先進細胞化驗
  • 各種化驗檢測手法·技術
  • 細胞化驗所採用的細胞
  • 藥物研發·藥物開發上細胞化驗的利用

第3章 全球細胞化驗市場預測

  • 全球細胞化驗市場預測
  • 市場促進因素
  • 市場成長的阻礙要素
  • 市場區隔:產品與服務
  • 產品部門的預測
    • 細胞化驗產品的4種主要類別
      • 設備
      • 拋棄式用品
      • 消耗品
      • 生物銀行
  • 服務部門的預測
    • 服務市場預測
  • 各用途市場的預測
    • 藥物研發
    • ADME (吸收·分佈·代謝·排泄)
    • 基礎研究

第4章 主要國家市場預測

  • 全球細胞化驗市場實際成果·預測:各地區明細
  • 全球細胞化驗市場:各地區的變化與預測
  • 美國的收益預測
  • 歐盟市場預測
  • 日本的收益預測
  • 金磚四國市場預測

第5章 主要產品供應商

  • Thermo Fisher Scientific
  • DiscoveRx
  • PerkinElmer
  • BD (Becton, Dickinson and Company)
  • InSphero
  • QGel
  • Biocroi
  • GE Healthcare
  • Molecular Devices
  • Promega
  • BioVision

第6章 主要CRO/服務供應商

  • Porsolt: Acquires Fluofarma
  • CYTOO
  • Cell Assay Innovations (CAI)
  • ProQinase
  • Charles River Laboratories
  • BioAgilytix
  • SGS
  • Pharmaceutical Product Development
  • Marin Biologic Laboratories

第7章 細胞化驗技術趨勢·未來展望

  • 幹細胞:龐大的可能性
  • 毒性實驗:細胞化驗的重要領域
  • 3D系統:下一代細胞系統的優點
  • 細胞化驗外包的擴大
  • 免標定技術
  • GPCR:共同的藥物·開發藥劑中標的
  • 小型化與自動化的發展
  • 微流體
  • 多重化:改善細胞化驗的效率
  • 高內涵篩選:確立的工具
  • 生物製藥開發上的細胞化驗

第8章 細胞化驗市場定性分析

  • SWOT分析
  • STEP分析

第9章 專家的採訪

第10章 詳論

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: PHA0119

Cell assaying for pharma - prospects for technologies shaping that medical testing

Visiongain's new report, Cell-Based Assays World Industry and Market Prospects 2016-2026: Products, Services, Drug Discovery, ADME and Basic Research, examines those companies, trends, products, services and technologies. It investigates how those forces will shape that bioassays industry over the next ten years. To support that analysis with data, our study shows revenue forecasts at overall world, submarket and national level. Its purpose is to help companies and other organisations understand the potential of that cellular testing for medicine.

Use of cell lines in bioassays becomes more important in drug discovery and development. The cost of developing a new drug is now estimated to be around $2.6bn. Set against that background of rising costs, cell-based assays have become a vital tool for drug discovery, development and basic research. Those assays provide many advantages over traditional biochemical assays and animal models, and are continuing to improve owing to advances in high-throughput screening (HTS) technology, automation and miniaturisation. Cell-based assays can provide a more-accurate representation of human in vivo conditions; they are reliable and, most important for drug development companies, they have high efficiency.

Increasing prominence of technologies such as microfluidics, label-free systems, 3D cell-based assays and IPSC cell lines will stimulate revenue growth in the cellular testing market from 2015. As with any other market, it holds challenges. These include high initial set-up costs, high complexity, need for skilled staff to run and analyse tests, and long developmental times for new products. However, visiongain predicts the cell-based assays market will grow strongly from 2016 to 2026, presenting many opportunities for assay product developers and suppliers, large CROs and specialist service providers, as well as many benefits for pharmaceutical companies.

Our work segments that bioassaying industry and market into two broad categories, with revenue forecasts to 2026 and discussions:

  • Products
  • Services

We also divide that medical testing industry into three main applications, again with sales forecasting:

  • Drug discovery uses
  • ADME (absorption, distribution, metabolism, excretion) testing
  • Basic research purposes

Besides forecasting revenues for the previous submarkets, our study also breaks its overall world market prediction into these 11 leading national markets, to 2026:

  • United States (US)
  • Japan
  • Germany, United Kingdom (UK), France, Spain, Italy (EU5 countries)
  • Brazil, Russia, India, China (BRIC nations)

And here lie technologies and trends we cover, among others, showing how they shape that worldwide market to 2026:

  • Stem cells (including IPSCs) for bioassays
  • 3D cell-based systems
  • Cell-based assaying for toxicity testing
  • Increased outsourcing for that cellular screening
  • Label-free technology
  • GPCRs (G-protein-coupled receptors)
  • Miniaturisation and automation
  • Microfluidics and multiplexing
  • High-content screening (HCS)
  • Cell lines for pharma in vitro assays
  • Cellular tests for the development of biologics (biological drugs)

Our 185 page report provides 48 tables and 66 figures covering different market segments categorized by application: drug discovery, ADME, and basic research; as well as by sector: products and services.

Moreover, 11 individual national markets are covered in addition to 20 leading companies which sell products and provide services.

Cell-Based Assays World Industry and Market Prospects 2016-2026: Products, Services, Drug Discovery, ADME and Basic Research, published in May 2016, adds to visiongain's range of reports on industries and markets in healthcare. Its portfolio includes studies on pharmaceuticals, medical devices, diagnostic tests and outsourced services, including contract researchers, manufacturers and sellers.

Ways Cell-Based Assays World Industry and Market Prospects 2016-2026: Products, Services, Drug Discovery, ADME and Basic Research helps:

In particular, our new investigation gives you this knowledge to benefit your research, analyses and planning:

  • Revenues for cellular assays, to 2026, at world level and for five submarkets - explore the prospects for design, production, sales, marketing, demand and spending
  • Forecasts, to 2026, for 11 countries in the Americas, Europe and Asia - assess the developed and developing national markets for demand and predicted revenues
  • Prospects for established firms, rising companies and new entrants - examine the product and service portfolios, results, strategies and outlooks for success
  • Analyses of what stimulates and restrains that industry's participants - investigate the challenges, strengths and competition affecting organisations' actions
  • Interviews with authorities in that field - discover what participants from the industry think, say and do, helping you stay ahead in business knowledge.

Information found nowhere else, benefiting your insight, work and influence

Our study, produced in-house by our UK-based analysts, provides independent knowledge. You will gain competitive intelligence found only in our report, finding where the progress and business prospects exist.

With our definitive market data you're less likely to fall behind in information or miss an opportunity. See how you could save time and effort. And, through your choice, benefit your plans, decisions and authority, helping you gain competitive advantages.

Data to help your knowledge of pharma R&D - benefit from our study now

Our new analysis is for everyone investigating pharmaceutical research and development. For cellular assaying systems, you can explore the trends, results and revenue forecasts. So avoid missing out - please get that report here now.

visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Cell-Based Assays Overview
  • 1.2. Cell-Based Assays Market Segmentation
  • 1.3. Why You Should Read This Report
  • 1.4. How This Report Delivers
  • 1.5. Questions Answered by this Report
  • 1.6. Who is this Report for?
  • 1.7. Research Methods and Analysis
  • 1.8. Frequently Asked Questions
  • 1.9. Associated Reports
  • 1.10. About Visiongain

2. Introduction to Cell-Based Assays and Applications

  • 2.1. Cost of New Drug Discovery and Development Reaches $2.6bn - Companies Constantly Looking for Increased Efficiencies
  • 2.2. Drug Discovery Approaches - Target-Based and Phenotype-Based Discovery
  • 2.3. Drug Screening Assays
  • 2.4. Animal Models Present In Vivo Conditions: But Do Results Translate to Humans?
  • 2.5. Biochemical Assays and their Advantages over Animal Models
    • 2.5.1. Applications of Biochemical Assays
    • 2.5.2. Lead Identification and Toxicity Testing
  • 2.6. Cell-Based Assays and their Advantages
  • 2.7. 2D vs 3D Cell-Based Assays
  • 2.8. Advanced Cell-Based Assays
  • 2.9. The Different Assay Detection Methods and Technologies
  • 2.10. Cells used in Cell-Based Assays
    • 2.10.1. Immortalised Cell Lines - Convenient but not Truly Representative of Normal Human Cell Lines
    • 2.10.2. Primary Cells: Closer to the In Vivo Environment
    • 2.10.3. Stem Cells: Potential to Overcome Limitations of Primary cells and Immortalised Cell Lines
  • 2.11. Uses for Cell-Based Assays in Drug Discovery and Development
    • 2.11.1. Target Validation
    • 2.11.2. Primary Screening
    • 2.11.3. Secondary Screening
    • 2.11.4. ADME Screening
    • 2.11.5. High Throughput Screening: Greatly Increases Efficiency

3. World Cell-Based Assays Market 2016-2026

  • 3.1. Global Cell-Based Assays Market Forecast 2016-2026
  • 3.2. Drivers for the Cell-Based Assays Market
  • 3.3. Restraints for the Cell-Based Assays Market
  • 3.4. Cell-Based Assays: Market Segments - Products and Services
  • 3.5. Cell-Based Assays, Market Segments: Products Forecast 2016-2026
    • 3.5.1. The Four Main Categories of Cell-Based Assay Products
      • 3.5.1.1. Equipment Needed to Conduct Cell-Based Assays
      • 3.5.1.2. Disposables Necessary to Perform Cell-Based Assays
      • 3.5.1.3. Consumables Forming the Basis of Cell-Based Assays
      • 3.5.1.4. Biobanks
  • 3.6. Cell-Based Assays Market Segments: Services
    • 3.6.1. Cell-Based Assays Market Segments: Services Forecast 2016-2026
  • 3.7. Cell-Based Assays Market: Applications Forecasts 2016-2026
    • 3.7.1. Drug Discovery Segment
    • 3.7.2. ADME (Absorption, Distribution, Metabolism, Excretion) Segment
    • 3.7.3. Basic Research Segment

4. Leading National Markets for Cell-Based Assays, 2016-2026

  • 4.1. Regional Breakdown of the Global Cell-Based Assays Market, 2016-2026
  • 4.2. Global Cell-Based Assays market: Regional Forecast 2016-2026
  • 4.3. The US Cell-Based Assays Revenue Forecast 2016-2026
  • 4.4. European Union (EU) Cell-Based Assays Market 2016-2026
    • 4.4.1. IMI's Pan-European Drug Discovery Platform holds Much Promise
    • 4.4.2. EU National Market Share Breakdown, 2015, 2020 and 2026
    • 4.4.3. EU Market: Main National Forecasts, 2016-2026
    • 4.4.4. German Cell-Based Assay Revenue Forecast, 2016-2026
    • 4.4.5. French Cell-Based Assays Revenue Forecast, 2016-2026
    • 4.4.6. UK Cell-Based Assays Revenue Forecast, 2016-2026
    • 4.4.7. Spanish Cell-Based Assays Revenue Forecast, 2016-2026
    • 4.4.8. Italian Cell-Based Assays Revenue Forecast, 2016-2026
  • 4.5. Japanese Cell-Based Assays Revenue Forecast, 2016-2026
  • 4.6. BRIC Nations (Brazil, Russia, India and China) Cell-Based Assays Market
    • 4.6.1. BRIC Countries National Breakdown, 2015, 2020 and 2026
    • 4.6.2. BRIC Countries National Forecasts, 2016-2026
    • 4.6.3. Chinese Cell-Based assay Revenue Forecast, 2016-2026
    • 4.6.4. Indian Cell-Based Assays Revenue Forecast, 2016-2026
    • 4.6.5. Russian Cell-Based Assays Revenue Forecast, 2016-2026
    • 4.6.6. Brazilian Cell-Based Assays Revenue Forecast, 2016-2026

5. Leading Companies in the Cell-Based Assays Market: Product Suppliers, 2016

  • 5.1. Thermo Fisher Scientific
    • 5.1.1. ThermoFisher Scientific Financial Figures
    • 5.1.2. Recent Developments at ThermoFisher Scientific
      • 5.1.2.1. ThermoFisher Acquires Affymetrix
    • 5.1.3. Cell-Based Assay Technologies under ThermoFisher's Life Science Solutions Segment
  • 5.2. DiscoveRx
    • 5.2.1. DiscoveRx Assay Platforms and Technology
  • 5.3. PerkinElmer
    • 5.3.1. AlphaScreen Technology
    • 5.3.2. DELFIA TRF Assays
    • 5.3.3. Label-Free Cellular Assay Detection/Opera System
  • 5.4. BD (Becton, Dickinson and Company)
    • 5.4.1. Cell-Based Assays Through BD Life Sciences
  • 5.5. InSphero
    • 5.5.1. GravityPLUS - Leading Solution for 3D Cell-Based Assays
  • 5.6. QGel
    • 5.6.1. QGel Products and Services
  • 5.7. Biocroi
    • 5.7.1. Happy Cell ASM and its 3D Cell Culture
  • 5.8. GE Healthcare
    • 5.8.1. Cell-Based Assays Through GE Healthcare Life Sciences
  • 5.9. Molecular Devices
  • 5.9.1. Cell-Based Assay Products Include SpectraMax Microplate Readers and FLIPR Tetra System
  • 5.10. Promega
    • 5.10.1. Assays Range from Cell Viability Assays to Mitochondrial Function Assays
  • 5.11. BioVision
    • 5.11.1. Cell-Based Assays Include the EZCell Platform and a Cholesterol Detection Kit

6. Leading Companies in the Cell-Based Assays Market: CROs and Service Providers, 2016

  • 6.1. Porsolt: Acquires Fluofarma
    • 6.1.1. Fluofarma
    • 6.1.2. Fluofarma has Over 100 Cell-Based Assays
  • 6.2. CYTOO
    • 6.2.1. Cell Micropatterning to Eliminate Trade-off Between Quantity and Quality?
    • 6.2.2. Cell-Based Assays for Muscular Atrophy/Hypertrophy and Anti-Cancer Drug Profiling
  • 6.3. Cell Assay Innovations (CAI)
    • 6.3.1. ClariCELL Technology
  • 6.4. ProQinase
    • 6.4.1. ProQinase Cell-Based Assay Services, 2016
  • 6.5. Charles River Laboratories
    • 6.5.1. PhenoFocus - Portfolio of over 100 Primary Cell-Based Assays
  • 6.6. BioAgilytix
  • 6.7. SGS
    • 6.7.1. Offers a Range of Services, Including 3D Cell-Based Assays
  • 6.8. Pharmaceutical Product Development
  • 6.9. Marin Biologic Laboratories

7. Cell-Based Assays Technology, Trends and Future Outlook

  • 7.1. Stem Cells: Vast Potential
    • 7.1.1. The Benefits of Using Stem Cells in Cell-Based Assays
    • 7.1.2. iPSCs: An Uncontroversial and Abundant Source
    • 7.1.3. Companies Providing Stem Cell-Based Assays
  • 7.2. Toxicity Testing: Important Field for Cell-Based Assays
  • 7.3. 3D Systems: The Advantages of Next Generation of Cell Systems
    • 7.3.1. Complexity of 3D Systems is a Challenge but More are Reaching the Market
    • 7.3.2. Organoids - The Future of Drug Development?
      • 7.3.2.1. Hurdles to the Future Organoid Market
      • 7.3.2.2. Organoids Now and in the Future
    • 7.3.3. Bio-Printing for Drug Development: Using 3D Printing Technology
  • 7.4. Increasing Outsourcing of Cell-Based Assays
  • 7.5. Label-Free Technology
  • 7.6. GPCRs: A Common Drug and Drug Discovery Target
    • 7.6.1. GPCRs in Cell-Based Assays
    • 7.6.2. Allosteric GPCRs
  • 7.7. Increasing Miniaturisation and Automation
    • 7.7.1. Advantages of Miniaturisation
    • 7.7.2. Advantages of Automation
  • 7.8. Microfluids are Set to be a Trend
    • 7.8.1. The Potential Challenges to Microfluids
  • 7.9. Multiplexing: Improves Efficiency of cell-Based Assays
    • 7.9.1. Advantages will Drive Growth
  • 7.10. High Content Screening: A Well Established Tool
    • 7.10.1. The Future for HCS: Will Continue to Expand, Still Room for Innovation
  • 7.11. Cell-Based Assays for the Development of Biologics

8. Qualitative Analysis of the Cell-Based Assays Market, 2016

  • 8.1. SWOT Analysis of the Cell-Based Assays Market
    • 8.1.1. Strengths Within the Cell-Based Assay Market
    • 8.1.2. Weaknesses Within the Cell-Based Assays Market
    • 8.1.3. Opportunities for the Cell-Based Assays Market
    • 8.1.4. Threats to the Cell-Based Assays Market
  • 8.2. STEP Analysis of the Cell-Based Assays Market
    • 8.2.1. Social Factors
    • 8.2.2. Technological Factors
    • 8.2.3. Economic Factors
    • 8.2.4. Political Factors

9. Research Interviews

  • 9.1. Interview with Dr Colin Sanctuary, CEO of QGel
    • 9.1.1. On the Definition of Cell-Based Assays
    • 9.1.2. On QGel Company Background and QGel Offerings
    • 9.1.3. On the Cell-Based Assay Market Now and in the Future
    • 9.1.4. On the Challenges to Cell-Based Assays and the Cell-Based Assay Market
    • 9.1.5. On Considerations to Take when Purchasing Cell-Based Assays

10. Conclusions from the Research and Analysis

  • 10.1. Growth Has Been Driven by Advantages of Cell-Based Assays
  • 10.2. Current Status of the Market and its Growth Drivers
  • 10.3. The Most Dominant National Markets and Emerging Countries
  • 10.4. Future Trends and Technology
  • Associated Reports
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Report Evaluation Form

List of Tables

  • Table 1.1: Global Cell-Based Assays Market Regional Forecasts: Revenues ($m), AGR (%), CAGR (%), Market Shares (%), 2016-2026
  • Table 2.1: Main Parameters Required in Drug Discovery and Development
  • Table 2.2: Selected Label-Free Detection Technologies Used for Cell-Based Assays, 2016
  • Table 2.3: Cell-Based Assays for HTS in Drug Screening, 2016
  • Table 3.1: Global Cell-Based Assays Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2016-2026
  • Table 3.2: Global Cell-Based Assays Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2016-2026
  • Table 3.3: Cell-Based Assays Market Segments: Products Forecast - Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2016-2026
  • Table 3.4: Cell-Based Assays Market Segments: Services Forecast- Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2016-2026
  • Table 3.5: Cell-Based Assays Market Application Forecasts: Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2016-2026
  • Table 3.6: Drug Discovery Segment Forecast: Revenue ($m), AGR (%), CAGR (%), Market Share (%), 2016-2026
  • Table 3.7: ADME Segment Forecast: Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2016-2026
  • Table 3.8: Basic Research Segment Forecast: Revenue ($m), Market Share (%), AGR (%), CAGR (%), 2016-2026
  • Table 4.1: Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2015
  • Table 4.2: Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2020
  • Table 4.3: Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2026
  • Table 4.4: Global Cell-Based Assays Market Regional Forecasts: Revenues ($m), AGR (%), CAGR (%), Market Shares (%), 2016-2026
  • Table 4.5: US Cell-Based Assays Market Forecast: Revenues ($m), AGR (%),Market Shares (%), CAGR (%), 2016-2026
  • Table 4.6: EU Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), World Market Shares (%), CAGR (%), 2016-2026
  • Table 4.7: EU Market Breakdown by Leading Nation: EU Market Shares (%), Global Market Shares (%) and Revenues ($m), 2015
  • Table 4.8: EU Market Breakdown by Leading Nation: EU Market Shares (%), Global Market Shares (%) and Revenues ($m), 2020
  • Table 4.9: EU Market Breakdown by Leading Nation: EU Market Shares (%), Global Market Shares (%) and Revenues ($m), 2026
  • Table 4.10: EU Market, Leading Five National Forecasts: Revenue ($m), AGR (%),Market Share (%), CAGR (%), 2016-2026
  • Table 4.11: German Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
  • Table 4.12: French Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
  • Table 4.13: UK Cell-Based Assays Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
  • Table 4.14: Spanish Cell-Based Assays Market Forecast: Revenues ($m), 2016-2026
  • Table 4.15: Italian Cell-Based Assays Market Forecast: Revenues ($m), 2016-2026
  • Table 4.16: Japanese Cell-Based Assays Market Forecast: Revenues ($m), 2016-2026
  • Table 4.17: BRIC Countries Breakdown by Nation: BRIC market Shares (%), Global Market Shares (%) and Revenues ($m), 2015
  • Table 4.18: BRIC Countries Breakdown by Nation: EU market Shares (%), Global Market Shares (%) and Revenues ($m), 2020
  • Table 4.19: BRIC Countries Breakdown by Nation: EU market Shares (%), Global Market Shares (%) and Revenues ($m), 2026
  • Table 4.20: BRIC National Forecasts: Revenue ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
  • Table 4.21: Chinese National Forecasts: Revenue ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
  • Table 4.22: Indian National Forecasts: Revenue ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
  • Table 4.23: Russian National Forecasts: Revenue ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
  • Table 4.24: Brazilian National Forecasts: Revenue ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
  • Table 5.1: ThermoFisher Scientific Historical Sales: Revenue ($m), AGR (%), 2010-2015
  • Table 5.2: Life Technologies Cell-Based Assay Technology Overview, 2016
  • Table 5.3: Life Technologies Cell-Based Assay Technology Overview, 2016
  • Table 5.4: Other DiscoveRx Assay Platforms, 2016
  • Table 5.5: PerkinElmer Revenue Breakdown: Revenue ($m) for Fiscal Year Ending 3rd January 2016
  • Table 5.6: QGel Products and Services Cell-Based Assay Products, 2016
  • Table 5.7: GE Healthcare Life Sciences Cell-Based Assay Products, 2016
  • Table 6.1: ProQinase Cell-Based Assay Services, 2016
  • Table 6.2: Charles River Laboratories Revenue Breakdown: Revenue ($m), 2013-2015
  • Table 6.3: Cell-Based Assay Platforms, Details and Benefits Used by BioAgilytix , 2016
  • Table 7.1: Selected Companies with Involvement in Stem Cell-Based Assays, 2016
  • Table 7.2: Selected Companies Offering Label-Free Assay Systems, 2016

List of Figures

  • Figure 1.1: Cell-Based Assays Market Segmented by Application
  • Figure 1.2: Cell-Based Assays Market Segmented by Sector
  • Figure 1.3: Cell-Based Assays Products Market Segments
  • Figure 2.1: Stages of Pre-Clinical Drug Development
  • Figure 3.1: Global Cell-Based Assays Market Forecast: Revenue ($m), 2016-2026
  • Figure 3.2: Drivers and Restraints for the Cell-Based Assays Market, 2016
  • Figure 3.3: Cell-Based Assays Market Segments Forecasts: Revenue ($m), 2016-2026
  • Figure 3.4: Cell-Based Assays Market Segments: Products Forecast - Revenue ($m), 2016-2026
  • Figure 3.5: Cell-Based Assays Market Segments: Products Forecast - AGR (%), 2016-2026
  • Figure 3.6: Cell-Based Assay Products Overview, 2016
  • Figure 3.7: Cell-Based Assays Market Segments: Services Forecast - Revenue ($m), 2016-2026
  • Figure 3.8: Cell-Based Assays Market Segments: Services Forecast - AGR (%), 2016-2026
  • Figure 3.9: Cell-Based Assays Market Application Forecasts: Revenue ($m), 2016-2026
  • Figure 3.10: Drug Discovery Segment Forecast: Revenue ($m), 2016-2026
  • Figure 3.11: Drug Discovery Segment Forecast: AGR (%), 2016-2026
  • Figure 3.12: ADME Segment Forecast: Revenue ($m), 2016-2026
  • Figure 3.13: ADME Segment Forecast: AGR (%), 2016-2026
  • Figure 3.14: Basic Research Segment Forecast: Revenue ($m), 2016-2026
  • Figure 3.15: Basic Research Segment Forecast: AGR (%), 2016-2026
  • Figure 4.1: Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2015
  • Figure 4.2: Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2020
  • Figure 4.3: Cell-Based Assays Market Breakdown by Region: Revenues ($m), Market Shares (%), 2026
  • Figure 4.4: Global Cell-Based Assays Market, Regional Forecasts: Revenues ($m), 2016-2026
  • Figure 4.5: US Cell-Based Assays Market Forecast: Revenues ($m), 2016-2026
  • Figure 4.6: US Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 4.7: EU Cell-Based Assays Market Forecast: Revenues ($m), 2016-2026
  • Figure 4.8: EU Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 4.9: EU Market Breakdown by Nation: EU Market Shares (%), 2015
  • Figure 4.10: EU Market Breakdown by Nation: Revenues ($m), Market Shares (%), 2020
  • Figure 4.11: EU Market Breakdown by Nation: Revenues ($m), Market Shares (%), 2026
  • Figure 4.12: EU Market, Top National Forecasts: Revenue ($m), 2016-2026
  • Figure 4.13: German Cell-Based Assays Market Forecast: Revenues ($m), 2016-2026
  • Figure 4.14: German Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 4.15: French Cell-Based Assays Market Forecast: Revenues ($m), 2016-2026
  • Figure 4.16: French Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 4.17: UK Cell-Based Assays Market Forecast: Revenues ($m), 2016-2026
  • Figure 4.18: UK Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 4.19: Spanish Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 4.20: Spanish Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 4.21: Italian Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 4.22: Italian Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 4.23: Japanese Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 4.24: Japanese Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 4.25: BRIC Countries Breakdown by Nation: Market Shares (%), 2015
  • Figure 4.26: BRIC Countries Breakdown by Nation: Market Shares (%), 2020
  • Figure 4.27: BRIC Countries Breakdown by Nation: Market Shares (%), 2026
  • Figure 4.28: BRIC Countries Breakdown by Nation: Revenues ($m), 2016-2026
  • Figure 4.29: Chinese Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 4.30: Chinese Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 4.31: Indian Cell-Based Assays Market Forecast: Revenue ($m), 2016-2026
  • Figure 4.32: Indian Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 4.33: Russian Cell-Based Assays Market Forecast: Revenue ($m), 2016-2026
  • Figure 4.34: Russian Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 4.35: Brazilian Cell-Based Assays Market Forecast: Revenue ($m), 2016-2026
  • Figure 4.36: Brazilian Cell-Based Assays Market Forecast: AGR (%), 2016-2026
  • Figure 5.1: ThermoFisher Scientific Historical Sales: Revenue ($m), 2010-2015
  • Figure 5.2: PerkinElmer Revenue Breakdown: Revenue ($m) for Fiscal Year Ending 3rd January 2016
  • Figure 5.3: BD Revenue Breakdown: Revenue ($m), 2015
  • Figure 6.1: Charles River Laboratories Revenue Breakdown: Revenue ($m), 2013-2015
  • Figure 8.1: Strengths and Weaknesses of the Cell-Based Assay Market, 2016
  • Figure 8.2: Strengths and Weaknesses of the Cell-Based Assay Market, 2016
  • Figure 9.1: Projected growth from 2000-2025 with and without a solution for industrialisation of advanced 3D cell-based assays.
  • Figure 9.2: Proportion of Types of Cell Based Assay Used n 2014 and Predicted in 2024
  • Figure 10.1: The Cell-Based Assay Submarket Revenue ($m) Breakdown by Products and Services, 2015, 2020 and 2026
  • Figure 10.2: The Cell-Based Assay Submarket Revenue ($m) Breakdown by Application: Drug Discovery, ADME and Basic Research, 2015, 2020 and 2026
  • Figure 10.3: Regional Breakdown of the Cell-Based Assay Market by Revenue ($m), 2015, 2020 and 2026

Companies Listed

  • Affymetrix
  • Alliance Regenerative Medicine
  • AstraZeneca
  • ATCC
  • Axiogenesis
  • Bayer
  • BBC (British Broadcasting Corporation)
  • BD (Becton, Dickinson and Company)
  • Bio-Rad
  • BioAgilytix
  • BioCity
  • Biocroi
  • Biofocus
  • BioSeek
  • BioVision
  • BMG Labtech
  • CareFusion Corporation
  • Cell Assay Innovations (CAI)
  • Cellartis (Takara Bio)
  • Cellomics
  • Cellular Dynamics
  • Charles River Laboratories
  • Corning
  • Covance
  • CXR Biosciences
  • Cyprotex
  • Cytek
  • CYTOO
  • Di Carlo Laboratory
  • DiscoveRx
  • Dr. Reddy's Laboratories
  • ESI BIO (BioTime)
  • European Lead Factory
  • Eurostars
  • Evotec
  • Fisher Scientific
  • Fluofarma
  • ForteBio
  • Foundation Top Institute Pharma
  • GE Healthcare
  • GenCell
  • General Electric (GE)
  • Harlan Laboratories
  • Hubrecht Institute
  • Imagen Biotech
  • InSphero
  • Janssen
  • Japan Institute of Biomedical Research
  • Jubilant Biosys
  • Lead Discovery Centre GmbH
  • Life Technologies Corporation
  • Marin Biologic Laboratories
  • Maxcyte
  • Merck & Co.
  • Molecular Devices
  • Netherlands Cancer Institute
  • OcellO
  • Organovo
  • PerkinElmer
  • Pharmaceutical Product Development (PPD)
  • Pharmacyclics
  • PharmaTimes
  • Princeton University
  • Promega
  • ProQinase
  • QGel
  • Quintiles
  • ReNeuron
  • ReproCELL
  • Roche
  • Sanofi
  • Seahorse Bioscience
  • SGS (Société Générale de Surveillance)
  • Solvo
  • SRU Biosystems
  • Swiss Federal Institute of Technology
  • SymCel
  • Syncom
  • The European Lead Factory (ELF)
  • The Innovative Medicines Initiative (IMI)
  • The National Health Service (NHS)
  • The Netherlands Cancer Institute
  • The Scientist Magazine
  • Thermo Electron
  • Thermo Fisher Scientific
  • Trinity College, Dublin
  • Tufts Center for the Study of Drug Development
  • UCB (Union Chimique Belge)
  • UCLA (University of California, Los Angeles)
  • UK Department of Health
  • University of Kyoto
  • University of Oxford
  • University of Zurich
  • US Congress
  • US FDA
  • Vala Sciences
  • WuXi
Back to Top